// Publications

// Select publication year: 2017
140. ADHERE: randomized controlled trial comparing renal function in de novo kidney transplant recipients receiving prolonged-release tacrolimus plus mycophenolate mofetil or sirolimus. Transpl Int. 2017, 30(1):83-95. (IF 2.7)

Rummo OO, Carmellini M, Rostaing L, Oberbauer R, Christiaans MH, Mousson C, Langer RM, Citterio F, Charpentier B, Brown M, Kazeem G, Lehner F; ADHERE study investigators

139. Survival analysis of conservative vs. dialysis treatment of elderly patients with CKD stage 5. PLOS ONE 2017, 12(7):e0181345 (IF 2.9)

Reindl-Schwaighofer R, Kainz A, Kammer M, Dumfarth A, Oberbauer R

138. Diffuse Extent of Peritubular Capillaritis in Late Antibody-mediated Rejection: Associations With Levels of Donor-specific Antibodies and Chronic Allograft Injury. Transplantation 2017, 101(5):e178-e187 (IF 5.3)

Kozakowski N1, Eskandary F, Herkner H, Bond G, Oberbauer R, Regele H, Böhmig GA, Kikić Ž

137. Developing consensus-based priority outcome domains for trials in kidney transplantation: a multinational Delphi survey with patients, caregivers and health professionals. Transplantation 2017, 101(8):1875-1886 (IF 5.3)

Sautenet B, Tong A, Manera KE, Chapman JR, Warrens AN, Rosenbloom D, Wong G, Gill J, Budde K, Rostaing L, Marson L, Josephson MA, Reese PP, Pruett TL, Hanson CS, O’Donoghue D, Tam-Tham H, Halimi JM, Shen JI, Kanellis J, Scandling JD, Howard K, Howell M, Cross N, Evangelidis N, Masson P, Oberbauer R, Fung S, Jesudason S, Knight S, Mandayam S, McDonald S, Chadban S, Rajan T, Craig JC

136. Positioning of tacrolimus for the treatment of diabetic nephropathy based on computational network analysis. Plos One 2017, 12(1):e0169518 (IF 2.9)

Aschauer C, Perco P, Heinzel A, Sunzenauer J, Oberbauer R

135. Steroid withdrawal after renal transplantation: a retrospective cohort study. BMC Med. 2017 Jan 12;15(1):8 (IF 7)

Haller M, Kammer M, Kainz A, Bear HJ, Heinze G, Oberbauer R

134. Systems biology derived biomarkers to predict progression of renal function decline in type 2 diabetes mellitus. Diabetes Care 2017, 40(3):391-397 (IF 14.8)

Mayer G, Heerspink HL, Aschauer C, Heinzel A, Heinze G, Kainz A, Sunzenauer J, Perco P, de Zeeuw D, Rossing P, Pena M, Oberbauer R

133. Dialysis Vintage and Outcomes after Kidney Transplantation: A Retrospective Cohort Study. CJASN 2017 12(1):122-130 (IF 8.5)

Haller M, Kainz A, Baer H, Oberbauer R

132. Prognostic value of bone- and vascular derived molecular biomarkers in hemodialysis and renal transplant patients: a systematic review and meta-analysis. Nephrol Dial Transplant 2017;32(9):1566-1578 (IF 4.8)

Pichler G, Haller MC, Kainz A, Wolf M, Redon J, Oberbauer R

131. miR-182-5p Inhibition Ameliorates Ischemic Acute Kidney Injury. Am J Pathol 2017, 187(1):70-79 (IF 6)

Wilflingseder J, Jelencsics K, Bergmeister H, Sunzenauer J, Regele H, Eskandary F, Reindl-Schwaighofer R, Kainz A, Oberbauer R

130. Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening Study. Transplantation 2017, 101(3):631-641 (IF 5.3)

Eskandary F, Bond G, Kozakowski N, Regele H, Marinova L, Wahrmann M, Kikić Ž, Haslacher H, Rasoul-Rockenschaub S, Kaltenecker CC, König F, Hidalgo LG, Oberbauer R, Halloran PF, Böhmig GA

SCIENTIFIC COLLABORATIONS